Literature DB >> 2903103

Effects of oestrogen on the expression of a 4.4 kb mRNA in the ZR-75-1 human breast cancer cell line.

D L Manning1, R J Daly, P G Lord, K F Kelly, C D Green.   

Abstract

A cDNA library has been constructed from the poly(A)+ mRNA of oestrogen-stimulated ZR-75-1 human breast cancer cells. Screening by differential hybridization has identified eight clones which are stimulated between 4- and 16-fold by oestrogen. Two clones (pLIV-1) that are stimulated 4-fold, hybridize to three different mRNA species. A further five recombinants encode for a mRNA 600 bp long which is induced greater than 16-fold and have been shown to cross-hybridize to the oestrogen-responsive clone, pS2, isolated from the MCF-7 breast cancer cell line. Oestradiol was shown to be without detectable effect upon the expression of mRNA for dihydrofolate reductase, which is reported to be oestrogen regulated in MCF-7 cells. Actin gene expression is also unresponsive to oestradiol in ZR-75-1 cells. These results suggest that pLIV-1 represents a previously unidentified mRNA that may be involved in the oestrogen-regulated growth of ZR-75-1 human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903103     DOI: 10.1016/0303-7207(88)90105-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  22 in total

1.  Regulation of zinc transporters by dietary zinc supplement in breast cancer.

Authors:  Daoxu Sun; Lianying Zhang; Yongsheng Wang; Xiaolei Wang; Xiaoyan Hu; Fu-Ai Cui; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-05-01       Impact factor: 2.316

2.  Mammary gland zinc metabolism: regulation and dysregulation.

Authors:  Shannon L Kelleher; Young Ah Seo; Veronica Lopez
Journal:  Genes Nutr       Date:  2009-04-02       Impact factor: 5.523

3.  Effect of dietary iron deficiency and overload on the expression of ZIP metal-ion transporters in rat liver.

Authors:  Hyeyoung Nam; Mitchell D Knutson
Journal:  Biometals       Date:  2011-08-09       Impact factor: 2.949

4.  The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.

Authors:  David Metalli; Francesca Lovat; Farida Tripodi; Marco Genua; Shi-Qiong Xu; Michela Spinelli; Lilia Alberghina; Marco Vanoni; Raffaele Baffa; Leonard G Gomella; Renato V Iozzo; Andrea Morrione
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

5.  Structure-function analysis of LIV-1, the breast cancer-associated protein that belongs to a new subfamily of zinc transporters.

Authors:  Kathryn M Taylor; Helen E Morgan; Andrea Johnson; Lisa J Hadley; Robert I Nicholson
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

6.  Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes.

Authors:  R A McClelland; D L Manning; J M Gee; E Anderson; R Clarke; A Howell; M Dowsett; J F Robertson; R W Blamey; A E Wakeling; R I Nicholson
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 7.  Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.

Authors:  Aiko Nagayama; Leif W Ellisen; Bruce Chabner; Aditya Bardia
Journal:  Target Oncol       Date:  2017-12       Impact factor: 4.493

8.  Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.

Authors:  Hui Shen; Haihong Qin; Junsheng Guo
Journal:  Mol Biol Rep       Date:  2008-03-11       Impact factor: 2.316

9.  Regulation of zinc transporters by dietary flaxseed lignan in human breast cancer xenografts.

Authors:  Lian-ying Zhang; Xiao-lei Wang; Dao-xu Sun; Xian-xi Liu; Xiao-yan Hu; Feng Kong
Journal:  Mol Biol Rep       Date:  2007-09-05       Impact factor: 2.316

Review 10.  Zinc and cancer: implications for LIV-1 in breast cancer.

Authors:  Bruce J Grattan; Hedley C Freake
Journal:  Nutrients       Date:  2012-07-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.